| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President
1 company
Srdjan R. Stankovic last filed a Form 4 in November 2022, as President at ACAD. From October 2019 to November 2022, the filings on record show 0 open-market purchases and 19 sales. Srdjan R. Stankovic's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
Historically, Srdjan R. Stankovic's trades have earned a middling insider score of 62/100 across 9 rated trades. Over a 12-month horizon, 66.7% of those trades were profitable, with an average 12-month return of +3.5%.
At the last filing, the largest reported position was 61,234 shares of ACAD. The ACAD filings lean toward selling, a net 386,840 shares.
Shares as reported in the last Form 4 for each company; the most recent is from November 2022. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jan 8, 2021 | ACAD Acadia Pharmaceuticals Inc | President | Sale+OE | 93,077 | $55.12 | $5,130,030.62 | -82.1% | |
| Nov 20, 2020 | ACAD Acadia Pharmaceuticals Inc | President | Sale+OE | 2,728 | $53.50 | $145,948.00 | -14.2% | |
| Oct 16, 2020 | ACAD Acadia Pharmaceuticals Inc | President | Sale+OE | 1,297 | $42.56 | $55,200.32 | -9.1% | |
| Jun 19, 2020 | ACAD Acadia Pharmaceuticals Inc | President | Sale+OE | 82,295 | $50.03 | $4,117,244.43 | -87.9% | |
| Apr 30, 2020 | ACAD Acadia Pharmaceuticals Inc | President | Sale+OE | 4,308 | $49.21 | $211,996.68 | -27.5% | |
| Apr 23, 2020 | ACAD Acadia Pharmaceuticals Inc | President | Sale+OE | 18,949 | $50.07 | $948,729.06 | -75.9% | |
| Apr 22, 2020 | ACAD Acadia Pharmaceuticals Inc | President | Sale+OE | 154,019 | $50.11 | $7,717,356.14 | -96.2% | |
| Nov 19, 2019 | ACAD Acadia Pharmaceuticals Inc | President | Sale+OE | 2,160 | $46.41 | $100,245.60 | -26.4% | |
| Oct 15, 2019 | ACAD Acadia Pharmaceuticals Inc | President | Sale+OE | 1,031 | $39.65 | $40,879.15 | -34.7% |